It has also completed a PRE-Investigational New Drug (PIND) filing on Escozine®, through the US Food and Drug Administration (FDA), and is awaiting a response on the submission of its final data set. https://www.globenewswire.com/news-release/2021/06/29/2254737/0/en/Medolife-Rx-Enters-Partnership-Agreement-with-Leading-International-Distributor-Brings-Products-to-Mexico.html